Recruiting Amyloidosis Studies in Iowa City
About Amyloidosis Clinical Trials in Iowa City
Amyloidosis is a group of diseases in which abnormal proteins (amyloids) build up in organs and tissues, impairing their function. Types include AL, AA, and ATTR amyloidosis. Treatment depends on the type and may include chemotherapy, organ transplant, or targeted therapies.
There are currently 2 amyloidosis clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 1,510 participants. Research is being sponsored by Alnylam Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Amyloidosis Clinical Trials in Iowa City — FAQ
Are there amyloidosis clinical trials in Iowa City?
Yes, there are 2 amyloidosis clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Iowa City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.
Are clinical trials in Iowa City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.
What amyloidosis treatments are being tested?
The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for amyloidosis.
Data updated July 21, 2026 from ClinicalTrials.gov